BEFAST STUDY: [68Ga]Ga-FAPI total body PET/CT for Better and Faster imaging in cancerProtocol: [68Ga]Ga-FAPI total body PET/CT for improving diagnostic sensitivity and preoperative staging in gastroesophageal cancer and pancreatic cancer

Rigshospitalet0 个研究点目标入组 60 人开始时间: 2023年3月30日最近更新: 2024年7月22日

试验速览

暂无简介。

•Inclusion criteria for group A 1)Male or female, =/>18 years old 2)Patients with suspected pancreatic cancer based on morphological findings on standard imaging 3)CT, MRI or [18F]FDG PET/CT evaluated on MDT with no initial sign of distant metastases 4) Subjects must have been considered suitable for curative surgery at the time of the referral 5)Subjects must be able to read and understand the patient information in Danish to give informed consent. Inclusion criteria for group B 1)Male or female =/>18 years old 2)Histological verified carcinoma from the lower oesophagus, GEJ or stomach 3)Subjects must be considered operable and resectable at the time of referral for MDT 4)Subjects must be able to read and understand the patient information in Danish to give informed consent

•Exclusion criteria for group A 1)Pregnancy or lactation 2)Weight more than the maximum limit of a PET/CT-scanner bed ( 140 kg) 3)History of allergic reaction due to compounds similar to the chemical or biological composition of [68Ga]Ga-FAPI-46. Exclusion criteria for group B 1)The subject is not considered suitable for diagnostic laparoscopy and potentially curative treatment at the MDT-conference 2)Pregnancy or lactation 3)Weight more than the maximum limit of a PET/CT-scanner bed ( 140 kg) 4)History of allergic reaction due to compounds similar to the chemical or biological composition of [68Ga]Ga-FAPI-46

发起方